Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (351-360 of 743) with videos related to

Pageof 75
Sort By:
Nature Cell Biology|July 8, 2008
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancerVihren Kolev, Anna Mandinova, Juan Guinea-Viniegra, et al.
Cell Reports. Medicine|August 12, 2025
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individualsYasser Morsy, Barbara Hubeli, Patrick Turko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanomaJohn M Kirkwood, Lars Bastholt, Caroline Robert, et al.
Translational Oncology|April 22, 2014
An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 NegativeDaniela Lenggenhager, Alessandra Curioni-Fontecedro, Martina Storz, et al.
Cell|June 12, 2012
Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signalingBing Hu, Einar Castillo, Louise Harewood, et al.
Plos One|November 11, 2014
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanomaTarun Mehra, Gerd Grözinger, Steven Mann, et al.
Cancers|July 2, 2021
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database AnalysisFlorentia Dimitriou, Ramon Staeger, Melike Ak, et al.
Nature Reviews. Disease Primers|August 27, 2021
Cutaneous T cell lymphomaReinhard Dummer, Maarten H Vermeer, Julia J Scarisbrick, et al.
Nature Medicine|January 9, 2018
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Dermatology (Basel, Switzerland)|September 22, 2022
Swiss Recommendations for Cutaneous Basal Cell CarcinomaEgle Ramelyte, Mirjam C Nägeli, Robert Hunger, et al.
Pageof 75

Showing results (351-360 of 743) with videos related to

Sort By:
Pageof 75
Nature Cell Biology|July 8, 2008
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancerVihren Kolev, Anna Mandinova, Juan Guinea-Viniegra, et al.
Cell Reports. Medicine|August 12, 2025
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individualsYasser Morsy, Barbara Hubeli, Patrick Turko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanomaJohn M Kirkwood, Lars Bastholt, Caroline Robert, et al.
Translational Oncology|April 22, 2014
An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 NegativeDaniela Lenggenhager, Alessandra Curioni-Fontecedro, Martina Storz, et al.
Cell|June 12, 2012
Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signalingBing Hu, Einar Castillo, Louise Harewood, et al.
Plos One|November 11, 2014
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanomaTarun Mehra, Gerd Grözinger, Steven Mann, et al.
Cancers|July 2, 2021
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database AnalysisFlorentia Dimitriou, Ramon Staeger, Melike Ak, et al.
Nature Reviews. Disease Primers|August 27, 2021
Cutaneous T cell lymphomaReinhard Dummer, Maarten H Vermeer, Julia J Scarisbrick, et al.
Nature Medicine|January 9, 2018
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Dermatology (Basel, Switzerland)|September 22, 2022
Swiss Recommendations for Cutaneous Basal Cell CarcinomaEgle Ramelyte, Mirjam C Nägeli, Robert Hunger, et al.
Pageof 75